Geode Capital Management
UTMD icon

Geode Capital Management’s Utah Medical Products UTMD Stock Holding History

Geode Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.45M Buy
120,097
+32,302
+37% +$2.04M ﹤0.01% 2541
2025
Q4 		$4.91M Sell
87,795
-2,166
-2% -$126K ﹤0.01% 2785
2025
Q3 		$5.67M Sell
89,961
-24,855
-22% -$1.47M ﹤0.01% 2716
2025
Q2 		$6.54M Buy
114,816
+7,040
+7% +$383K ﹤0.01% 2593
2025
Q1 		$6.04M Buy
107,776
+9,839
+10% +$589K ﹤0.01% 2569
2024
Q4 		$6.02M Buy
97,937
+857
+0.9% +$55.4K ﹤0.01% 2652
2024
Q3 		$6.5M Buy
97,080
+8,516
+10% +$578K ﹤0.01% 2618
2024
Q2 		$5.92M Buy
88,564
+14,885
+20% +$1.01M ﹤0.01% 2630
2024
Q1 		$5.24M Buy
73,679
+1,659
+2% +$124K ﹤0.01% 2677
2023
Q4 		$6.07M Buy
72,020
+3,296
+5% +$273K ﹤0.01% 2606
2023
Q3 		$5.91M Buy
68,724
+2,396
+4% +$221K ﹤0.01% 2562
2023
Q2 		$6.18M Sell
66,328
-5,083
-7% -$479K ﹤0.01% 2577
2023
Q1 		$6.77M Buy
71,411
+1,085
+2% +$99.7K ﹤0.01% 2490
2022
Q4 		$7.07M Buy
70,326
+547
+0.8% +$49.9K ﹤0.01% 2473
2022
Q3 		$5.95M Buy
69,779
+1,715
+3% +$151K ﹤0.01% 2578
2022
Q2 		$5.85M Buy
68,064
+9,216
+16% +$786K ﹤0.01% 2617
2022
Q1 		$5.29M Buy
58,848
+2,082
+4% +$191K ﹤0.01% 2768
2021
Q4 		$5.68M Buy
56,766
+588
+1% +$60K ﹤0.01% 2831
2021
Q3 		$5.21M Sell
56,178
-451
-0.8% -$39.8K ﹤0.01% 2891
2021
Q2 		$4.82M Buy
56,629
+2,707
+5% +$234K ﹤0.01% 2934
2021
Q1 		$4.67M Buy
53,922
+793
+1% +$69.7K ﹤0.01% 2824
2020
Q4 		$4.48M Buy
53,129
+81
+0.2% +$6.91K ﹤0.01% 2661
2020
Q3 		$4.24M Buy
53,048
+682
+1% +$56.6K ﹤0.01% 2492
2020
Q2 		$4.64M Buy
52,366
+819
+2% +$73.5K ﹤0.01% 2381
2020
Q1 		$4.85M Buy
51,547
+1,662
+3% +$154K ﹤0.01% 2167
2019
Q4 		$5.38M Sell
49,885
-507
-1% -$51.4K ﹤0.01% 2408
2019
Q3 		$4.83M Sell
50,392
-1,974
-4% -$183K ﹤0.01% 2400
2019
Q2 		$5.01M Buy
52,366
+116
+0.2% +$9.77K ﹤0.01% 2391
2019
Q1 		$4.61M Buy
52,250
+2,543
+5% +$224K ﹤0.01% 2385
2018
Q4 		$4.13M Buy
49,707
+1,422
+3% +$125K ﹤0.01% 2329
2018
Q3 		$4.55M Buy
48,285
+2,273
+5% +$217K ﹤0.01% 2409
2018
Q2 		$5.07M Buy
46,012
+3,247
+8% +$339K ﹤0.01% 2312
2018
Q1 		$4.23M Sell
42,765
-6,419
-13% -$573K ﹤0.01% 2343
2017
Q4 		$4M Buy
49,184
+3,849
+8% +$300K ﹤0.01% 2333
2017
Q3 		$3.33M Buy
45,335
+3,118
+7% +$224K ﹤0.01% 2447
2017
Q2 		$3.06M Buy
42,217
+4,740
+13% +$312K ﹤0.01% 2476
2017
Q1 		$2.33M Buy
37,477
+1,550
+4% +$97.6K ﹤0.01% 2579
2016
Q4 		$2.61M Buy
35,927
+597
+2% +$38.8K ﹤0.01% 2475
2016
Q3 		$2.11M Sell
35,330
-86
-0.2% -$5.47K ﹤0.01% 2527
2016
Q2 		$2.23M Buy
35,416
+570
+2% +$36.8K ﹤0.01% 2404
2016
Q1 		$2.18K Buy
34,846
+4,815
+16% +$284K ﹤0.01% 2397
2015
Q4 		$1.76M Buy
30,031
+365
+1% +$20.7K ﹤0.01% 2564
2015
Q3 		$1.6M Buy
29,666
+759
+3% +$41.4K ﹤0.01% 2583
2015
Q2 		$1.72M Buy
28,907
+254
+0.9% +$14.3K ﹤0.01% 2598
2015
Q1 		$1.72M Buy
28,653
+14,976
+109% +$880K ﹤0.01% 2539
2014
Q4 		$821K Buy
13,677
+473
+4% +$26.2K ﹤0.01% 2952
2014
Q3 		$643K Buy
13,204
+412
+3% +$20.9K ﹤0.01% 3044
2014
Q2 		$658K Buy
12,792
+1,372
+12% +$70.4K ﹤0.01% 3034
2014
Q1 		$660K Buy
11,420
+2,703
+31% +$147K ﹤0.01% 3013
2013
Q4 		$498K Buy
8,717
+1,295
+17% +$71K ﹤0.01% 3092
2013
Q3 		$441K Buy
7,422
+476
+7% +$26K ﹤0.01% 3010
2013
Q2 		$377K Buy
+6,946
New +$327K ﹤0.01% 3002

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management's UTMD Position: Q1 2026 in Review

Geode Capital Management increased its Utah Medical Products (UTMD) stake by 37% in Q1 2026, buying an estimated $2.04M and bringing the position to 120,097 shares worth $7.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

Geode Capital Management first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Geode Capital Management held 120,097 shares of Utah Medical Products worth $7.45M as of Q1 2026.
  • Geode Capital Management bought 32,302 Utah Medical Products shares in Q1 2026, an estimated $2.04M.
  • Utah Medical Products made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2541 holding.
  • Geode Capital Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.